Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants

Michael A Singer1, Nancy Amir2, Angela Herro3, Salman S Porbandarwalla3, Joseph Pollard11Medical Center Ophthalmology Associates, San Antonio, TX, USA; 2Santa Rosa Low Vision Clinic, San Antonio, TX, USA; 3University of Texas Health Science Center at San Antonio, San Antonio, TX, USAAbstract: Low vi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Singer MA, Amir N, Herro A, Porbandarwalla SS, Pollard J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/a3304eca3f4d41b694b1c2e9b444932e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a3304eca3f4d41b694b1c2e9b444932e
record_format	dspace
spelling	oai:doaj.org-article:a3304eca3f4d41b694b1c2e9b444932e2021-12-02T04:10:45ZImproving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants1177-54671177-5483https://doaj.org/article/a3304eca3f4d41b694b1c2e9b444932e2011-12-01T00:00:00Zhttp://www.dovepress.com/improving-quality-of-life-in-patients-with-end-stage-age-related-macul-a8976https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Michael A Singer1, Nancy Amir2, Angela Herro3, Salman S Porbandarwalla3, Joseph Pollard11Medical Center Ophthalmology Associates, San Antonio, TX, USA; 2Santa Rosa Low Vision Clinic, San Antonio, TX, USA; 3University of Texas Health Science Center at San Antonio, San Antonio, TX, USAAbstract: Low vision devices in the past have been mainly extraocular. There are now four new devices in different stages of development and implementation that are currently available. Three of them, the Implantable Miniature Telescope (IMT, VisionCare Ophthalmic Technologies, Saratoga, CA), Intraocular Lens for Visually Impaired People (IOL-VIP, IOL-VIP System, Soleko, Pontecorvo, Italy), and Lipschitz Mirror Implant (LMI, Optolight Vision Technology, Herzlia, Israel) are implanted into the anterior segment while the Argus II (Second Sight Medical Products, Sylmar, CA) is implanted into the posterior segment. The goal of these devices is to increase the patient quality of life which has been measured by Visual Functioning Questionnaire (VFQ) scales. The IMT is the only device that has been shown to increase the VFQ score by seven points at 6 months compared to baseline. It is the only FDA-approved device in the US while the Argus has been approved in Europe. Each of these prosthetics has potential benefits for patients.Keywords: IMT, IOL-VIP, LMI, Argus II&nbsp;Singer MAAmir NHerro APorbandarwalla SSPollard JDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 33-40 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Singer MA Amir N Herro A Porbandarwalla SS Pollard J Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants
description	Michael A Singer1, Nancy Amir2, Angela Herro3, Salman S Porbandarwalla3, Joseph Pollard11Medical Center Ophthalmology Associates, San Antonio, TX, USA; 2Santa Rosa Low Vision Clinic, San Antonio, TX, USA; 3University of Texas Health Science Center at San Antonio, San Antonio, TX, USAAbstract: Low vision devices in the past have been mainly extraocular. There are now four new devices in different stages of development and implementation that are currently available. Three of them, the Implantable Miniature Telescope (IMT, VisionCare Ophthalmic Technologies, Saratoga, CA), Intraocular Lens for Visually Impaired People (IOL-VIP, IOL-VIP System, Soleko, Pontecorvo, Italy), and Lipschitz Mirror Implant (LMI, Optolight Vision Technology, Herzlia, Israel) are implanted into the anterior segment while the Argus II (Second Sight Medical Products, Sylmar, CA) is implanted into the posterior segment. The goal of these devices is to increase the patient quality of life which has been measured by Visual Functioning Questionnaire (VFQ) scales. The IMT is the only device that has been shown to increase the VFQ score by seven points at 6 months compared to baseline. It is the only FDA-approved device in the US while the Argus has been approved in Europe. Each of these prosthetics has potential benefits for patients.Keywords: IMT, IOL-VIP, LMI, Argus II&nbsp;
format	article
author	Singer MA Amir N Herro A Porbandarwalla SS Pollard J
author_facet	Singer MA Amir N Herro A Porbandarwalla SS Pollard J
author_sort	Singer MA
title	Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants
title_short	Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants
title_full	Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants
title_fullStr	Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants
title_full_unstemmed	Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants
title_sort	improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/a3304eca3f4d41b694b1c2e9b444932e
work_keys_str_mv	AT singerma improvingqualityoflifeinpatientswithendstageagerelatedmaculardegenerationfocusonminiatureocularimplants AT amirn improvingqualityoflifeinpatientswithendstageagerelatedmaculardegenerationfocusonminiatureocularimplants AT herroa improvingqualityoflifeinpatientswithendstageagerelatedmaculardegenerationfocusonminiatureocularimplants AT porbandarwallass improvingqualityoflifeinpatientswithendstageagerelatedmaculardegenerationfocusonminiatureocularimplants AT pollardj improvingqualityoflifeinpatientswithendstageagerelatedmaculardegenerationfocusonminiatureocularimplants
_version_	1718401390716387328

Improving quality of life in patients with end-stage age-related macular degeneration: focus on miniature ocular implants

Ejemplares similares